← back to search

Laura Cooper

University of Illinois Chicago · US
🔎 Find collaborators in Infectious Diseases · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include Chemistry, Virology, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Protease, Proteases, and Aptamer.
h-index
citations
1,406
works
23
NIH funding
primary concept
email

Recent publications

Bioinspired designer DNA NanoGripper for virus sensing and potential inhibition
Science Robotics 2024cited by 38position: middledoi
Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition
Journal of the American Chemical Society 2024cited by 21position: middledoi
An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil
Science Advances 2024cited by 20position: middledoi
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity
Journal of Medicinal Chemistry 2024cited by 15position: middledoi
Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification
Nature Microbiology 2024cited by 8position: middledoi
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors
Journal of Medicinal Chemistry 2024cited by 6position: middledoi
Suppression of interferon α and γ response by Huwe1-mediated Miz1 degradation promotes SARS-CoV-2 replication
Frontiers in Immunology 2024cited by 3position: middledoi
Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2
Journal of Medical Virology 2023cited by 17position: middledoi
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
Nature Chemical Biology 2022cited by 89position: middledoi
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
Cell Reports 2022cited by 58position: middledoi
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐2
EMBO Molecular Medicine 2022cited by 53position: middledoi
Synthesis, Optimization, and Structure–Activity Relationships of Imidazo[1,2-<i>a</i>]pyrimidines as Inhibitors of Group 2 Influenza A Viruses
Journal of Medicinal Chemistry 2022cited by 25position: middledoi
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
Journal of Medicinal Chemistry 2021cited by 210position: middledoi
Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors
Science Advances 2021cited by 160position: middledoi
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
Cell & Bioscience 2021cited by 71position: middledoi
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro
Antiviral Research 2021cited by 71position: middledoi
Targeting SARS‐CoV‐2 viral proteases as a therapeutic strategy to treat COVID‐19
Journal of Medical Virology 2021cited by 63position: middledoi
ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2
iScience 2021cited by 48position: middledoi
Label-Free Digital Detection of Intact Virions by Enhanced Scattering Microscopy
Journal of the American Chemical Society 2021cited by 47position: middledoi
Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry
PLoS Pathogens 2021cited by 32position: middledoi
A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery
Antiviral Research 2021cited by 18position: middledoi
Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors
Journal of Medicinal Chemistry 2020cited by 25position: firstdoi
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
Frontiers in Immunology 2019cited by 308position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lijun Rong · University of Illinois Chicago23 papers (2019–2024)Hyun Lee · University of Illinois Chicago5 papers (2021–2021)Gregory R. J. Thatcher · University of Illinois Chicago5 papers (2020–2024)Jazmin Galván Achi · University of Illinois Chicago4 papers (2022–2024)Irina N. Gaisina · University of Illinois Chicago4 papers (2021–2024)Han Cheng · University of Illinois Chicago4 papers (2020–2021)Terry W. Moore · University of Illinois Chicago4 papers (2021–2024)Rui Xiong · University of Illinois Chicago4 papers (2020–2024)Ruikun Du · University of Illinois Chicago4 papers (2021–2024)Xing Wang · New York University3 papers (2021–2024)Qinghua Cui · University of Illinois Chicago3 papers (2021–2023)Zinuo Chen · Shandong University of Traditional Chinese Medicine3 papers (2021–2023)Norton P. Peet · National Institute of Allergy and Infectious Diseases3 papers (2021–2024)Yangfeng Li · University of Illinois Chicago3 papers (2020–2021)Zhengnan Shen · University of Illinois Chicago3 papers (2020–2024)Brian T. Cunningham · University of Illinois Urbana-Champaign2 papers (2021–2024)Lianghui Zhang · University of Illinois Chicago2 papers (2022–2022)Jalees Rehman · Illinois College2 papers (2022–2022)Raghad Nowar · University of Illinois Chicago2 papers (2020–2021)Xiaojing Wang · University of Illinois Urbana-Champaign2 papers (2021–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Molecular Biology →